Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$0.21 - $0.36 $2,100 - $3,600
-10,000 Reduced 49.81%
10,075 $3,000
Q3 2023

Oct 24, 2023

BUY
$0.26 - $0.61 $1,259 - $2,954
4,843 Added 31.79%
20,075 $5,000
Q1 2023

May 11, 2023

BUY
$0.36 - $1.0 $5,483 - $15,232
15,232 New
15,232 $10,000
Q1 2022

May 12, 2022

SELL
$0.53 - $1.19 $2,650 - $5,950
-5,000 Reduced 19.25%
20,971 $13,000
Q4 2021

Feb 03, 2022

SELL
$1.03 - $2.31 $14,008 - $31,416
-13,600 Reduced 34.37%
25,971 $28,000
Q3 2021

Nov 02, 2021

SELL
$1.74 - $2.93 $10,440 - $17,580
-6,000 Reduced 13.17%
39,571 $73,000
Q2 2021

Aug 10, 2021

BUY
$1.52 - $3.62 $20,530 - $48,895
13,507 Added 42.13%
45,571 $144,000
Q1 2021

May 07, 2021

BUY
$0.9 - $6.32 $28,857 - $202,644
32,064 New
32,064 $104,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.